Sancho-Saldaña, A., Gil-Sánchez, A., González-Mingot, C., Peralta, S., Solana, M. J., Torres, P., . . . Brieva, L. (2023). Seroprevalence of SARS-CoV-2 in Patients with Multiple Sclerosis under Disease-Modifying Therapies: A Multi-Centre Study.
Citación estilo ChicagoSancho-Saldaña, Agustín, et al. Seroprevalence of SARS-CoV-2 in Patients With Multiple Sclerosis Under Disease-Modifying Therapies: A Multi-Centre Study. 2023.
Cita MLASancho-Saldaña, Agustín, et al. Seroprevalence of SARS-CoV-2 in Patients With Multiple Sclerosis Under Disease-Modifying Therapies: A Multi-Centre Study. 2023.
Precaución: Estas citas no son 100% exactas.